Release date: September 16, 2013
Expiration date: September 17, 2014
Estimated time to complete activity: 1 hour
Course viewing requirements:
PC: Internet Explorer (v6 or greater) or Firefox - MAC: Safari or Firefox

Jointly sponsored by Postgraduate Institute for Medicine (www.pimed.com) and Medtelligence.
This activity is supported by an educational grant from Boston Scientific

This program is not part of the Heart Rhythm 2012 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Program Committee. This activity is neither sponsored nor endorsed by the Heart Rhythm Society.

Target Audience
This activity has been designed to meet the educational needs of Electrophysiologists, EP Fellows and EP Lab Staff, Nurses, Nurse Practitioners, Physician Assistants, and other allied health professionals involved in the management of patients with cardiac arrhythmias.

Program Overview
This online activity is based on Customizing Management Decisions in the Era of Subcutaneous ICD Technology and Techniques held on May 9, 2012 at the Heart Rhythm Society’s 33rd Annual Scientific Sessions. Selected faculty presentations (audio and slides) include Update on New Technology, Weighing the Benefits & Risks of ICD Implantation, Reducing Inappropriate Shocks, and Real-World S-ICD Implantation Experience.

Learning Objectives
After completing this activity, the participant should be better able to:
• Utilize implantation techniques that avoid complications of vascular access
• Avoid complications with shock-only ICDs
• Choose appropriate devices for patients at high risk for arrhythmic death
• Describe the benefits of extravascular device implantation to preserve future vascular access needs

Faculty
Lucas V. Boersma, MD, PhD, is Chairman of the Cardiology Department and a practicing Electrophysiologist at St. Antonius Hospital in Nieuwegein, The Netherlands. Dr. Boersma earned his medical degree and PhD degree at Maastricht University (The Netherlands). He completed his cardiology training at St. Antonius Hospital, internal medicine training at Rijnstate Hospital (The Netherlands), and clinical electrophysiology training at the Hospital Clinic of Barcelona (Spain). Dr. Boersma is a reviewer for the European Heart Journal, Europace, HeartRhythm, PACE, and the Netherlands Heart Foundation. A member of both the ESC Taskforce for AF Guidelines and the Editorial Review board for the European Heart Journal, Dr. Boersma has been published in numerous peer-reviewed journals, including Circulation, New England Journal of Medicine, and International Journal of Cardiology.

Martin C. Burke, DO, is Professor of Medicine, Interim Chief in the Section of Cardiology, and Director of the Heart Rhythm Center at the University of Chicago Medical Center in Chicago, Illinois. Dr. Burke earned his DO degree at the Chicago College of Osteopathic Medicine and completed his residency and a fellowship in cardiovascular medicine at the Chicago Osteopathic Hospitals. His cardiac electrophysiology fellowship was completed at the University of Chicago. Dr. Burke’s clinical interests include the treatment of cardiac arrhythmias through intracardiac device and radiofrequency catheter ablation techniques, and the basic mechanisms and clinical applications of cardiac defibrillation. He is a regional expert in the management of infected cardiac devices. His major research interests involve ablative therapy for atrial fibrillation and ventricular tachycardia as well as the implantation and laser removal of therapeutic devices for cardiac arrhythmias. Dr. Burke has been published in HeartRhythm, Pacing and Clinical Electrophysiology, and the Journal of Cardiovascular Electrophysiology, among other peer-reviewed journals.

Michael R. Gold, MD, PhD, is the Chief of Cardiology, Michael E. Assey Professor of Medicine, and Medical Director of the Heart and Vascular Center at the Medical University of South Carolina in Charleston, South Carolina. Dr. Gold received his medical degree from the University of Colorado and his PhD degree from the University of Virginia. He completed his residency and a cardiology fellowship at Massachusetts General Hospital. He sits on the Editorial Board of several peer-reviewed journals, including American Journal of Cardiology, PACE, HeartRhythm, and Journal of Cardiac Electrophysiology. Dr. Gold’s major clinical research interests are in the areas of defibrillator optimization, risk stratification for sudden cardiac death, pacing for CHF, and ablation of cardiac arrhythmias. He is the national or global PI of several clinical studies, including RIGHT, ASSERT, REVERSE, and PROMISE. An author of over 250 publications, Dr. Gold is a pioneer in the development of new defibrillation techniques and pacing for congestive heart failure.

Physician Continuing Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Medtelligence, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lucas V. Boersma, MD: Consulting Fees: Cameron Health, Inc.; Fees for Non-CME/CE Services: Cameron Health, Inc.
Martin C. Burke, DO
: Consulting Fees: Boston Scientific Corporation, Cameron Health, Inc.; Contracted Research: Boston Scientific Corporation, Cameron Health, Inc., Medtronic, Inc.

Michael R. Gold, MD, PhD: Consulting Fees: Boston Scientific Corporation, Cameron Health, Inc., Medtronic, Inc., Sorin Group, St. Jude Medical, Inc.: Fees for Non-CME/CE Services: BIOTRONIK, Boston Scientific Corporation, Cameron Health, Inc., Medtronic, Inc., Sorin Group, St. Jude Medical, Inc.; Contracted Research: Boston Scientific Corporation, Medtronic, Inc., Sorin Group, St. Jude Medical, Inc.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Medtelligence, LLC: Ben Caref, PhD, and Pamela Clark hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this activity. During the period June 15, 2012 through September 17, 2014, participants must read the learning objectives and faculty disclosures and study the educational activity.PIM supports Green CME by offering your Request for Credit online.  If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu under course links, click on “Find Evaluation/Post-test” then Find Evaluation 8936. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Media
Internet

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Boston Scientific, and Medtelligence, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Boston Scientific, and Medtelligence, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.